Publications

  1. Di Florio DN, Macomb LP, Giresi PG, Beetler DJ, Bonvie-Hill NE, Shapiro KA, Naser AN, Khatib S, Whelan ER, Weigel GJ, Edenfield BH, Balamurugan V, Burris SK, Rich LJ, Bruno KA, Cooper LT Jr, McLeod CJ, Yamani MH, Fairweather D. Sex differences in left-ventricular strain in a murine model of coxsackievirus B3 myocarditis. iScience. 2023 Dec 15; 26 (12):108493 Epub 2023 Nov 20
    View PubMed
  2. Adedinsewo DA, Morales-Lara AC, Dugan J, Garzon-Siatoya WT, Yao X, Johnson PW, Douglass EJ, Attia ZI, Phillips SD, Yamani MH, Tobah YB, Rose CH, Sharpe EE, Lopez-Jimenez F, Friedman PA, Noseworthy PA, Carter RE. Screening for peripartum cardiomyopathies using artificial intelligence in Nigeria (SPEC-AI Nigeria): Clinical trial rationale and design. Am Heart J. 2023 Jul; 261:64-74. Epub 2023 Mar 25.
    View PubMed
  3. Adedinsewo D, Hardway HD, Morales-Lara AC, Wieczorek MA, Johnson PW, Douglass EJ, Dangott BJ, Nakhleh RE, Narula T, Patel PC, Goswami RM, Lyle MA, Heckman AJ, Leoni-Moreno JC, Steidley DE, Arsanjani R, Hardaway B, Abbas M, Behfar A, Attia ZI, Lopez-Jimenez F, Noseworthy PA, Friedman P, Carter RE, Yamani M. Non-invasive detection of cardiac allograft rejection among heart transplant recipients using an electrocardiogram based deep learning model. Eur Heart J Digit Health. 2023 Mar; 4 (2):71-80 Epub 2023 Jan 13
    View PubMed
  4. Travers PM, Yamani HM, Gomez V. Resolution of Obstruction in a Patient with Hypertrophic Obstructive Cardiomyopathy Following Bariatric Surgery Bariatric Times. 2023.
  5. Yousufuddin M, Yamani MH, Kashani KB, Zhu Y, Wang Z, Seshadri A, Blocker KR, Peters JL, Doss JM, Karam D, Khandelwal K, Sharma UM, Dudenkov DV, Mehmood T, Pagali SR, Nanda S, Abdalrhim AD, Cummings N, Dugani SB, Smerina M, Prokop LJ, Keenan LR, Bhagra S, Jahangir A, Bauer PR, Fonarow GC, Murad MH. Characteristics, Treatment Patterns, and Clinical Outcomes After Heart Failure Hospitalizations During the COVID-19 Pandemic, March to October 2020. Mayo Clin Proc. 2023 Jan; 98 (1):31-47 Epub 2022 Sept 21
    View PubMed
  6. Matar RH, Mansour R, Nakanishi H, Smayra K, El Haddad J, Vankayalapati DK, Daniel RS, Tosovic D, Than CA, Yamani MH. Clinical Characteristics of Patients with Myocarditis following COVID-19 mRNA Vaccination: A Systematic Review and Meta-Analysis. J Clin Med. 2022 Aug 3; 11 (15) Epub 2022 Aug 03
    View PubMed
  7. Patel PP, El Sabbagh A, Johnson PW, Suliman R, Salwa N, Morales-Lara AC, Pollak P, Yamani M, Parikh P, Sonavane SK, Landolfo C, Alkhouli MA, Eleid MF, Guerrero M, Fortuin FD, Sweeney J, Noseworthy PA, Carter RE, Adedinsewo D. Sex Differences in the Impact of Aortic Valve Calcium Score on Mortality After Transcatheter Aortic Valve Replacement. Circ Cardiovasc Imaging. 2022 Aug; 15 (8):e014034 Epub 2022 Aug 03
    View PubMed
  8. Krishnarao K, Bruno KA, Di Florio DN, Edenfield BH, Whelan ER, Macomb LP, McGuire MM, Hill AR, Ray JC, Cornell LF, Tan W, Geiger XJ, Salomon GR, Douglass EJ, Fairweather D, Yamani MH. Upregulation of Endothelin-1 May Predict Chemotherapy-Induced Cardiotoxicity in Women with Breast Cancer. J Clin Med. 2022 Jun 20; 11 (12) Epub 2022 June 20
    View PubMed
  9. Adedinsewo DA, Johnson PW, Douglass EJ, Attia IZ, Phillips SD, Goswami RM, Yamani MH, Connolly HM, Rose CH, Sharpe EE, Blauwet L, Lopez-Jimenez F, Friedman PA, Carter RE, Noseworthy PA. Detecting cardiomyopathies in pregnancy and the postpartum period with an electrocardiogram-based deep learning model. Eur Heart J Digit Health. 2021 Dec; 2 (4):586-596 Epub 2021 Aug 27
    View PubMed
  10. Farhat S, Mathew T, Yamani MH. Eosinophilic Myo-Pericarditis Presenting as Cardiac Tamponade Clinical Cardiology and Cardiovascular Interventions. 2019; 2(2).
  11. Sanchez Alvarez C, Werlang ME, Oluleye O, Yamani MH. A Case of Impending Cardiac Tamponade Caused by Effusive Constrictive Pericarditis Archives of Clinical and Medical Case Reports. 2018; 2(5):157-161.
  12. Gonzalez YO, Yamani MH, Pollak PM. Acute Cardiogenic Shock Secondary to Pazopanib with recovery after use of impella device International journal of cardiac science and research. 2018; 02.
  13. Ahmed S, Jani P, Yamani MH, Ailawadhi S, Alegria VR, Ailawadhi M. Marantic Endocarditis Associated With T-Cell Large Granular Lymphocytic Leukemia: First Report of Its Occurrence With a Lymphoproliferative Malignancy in Adults. J Oncol Pract. 2018 Oct; 14 (10):625-627 Epub 2018 Sept 17
    View PubMed
  14. Oluleye O, Ortiz Gonzalez Y, Yamani MH. New Pharmacologic Therapies for Heart Failure. Journal North East Florida Medicine .2017;().
  15. Farres Houssam, Yamani ,, Moualla ,, Hakaim AG. A novel chemical solution to demineralize vascular calcification in ex-vivo amputated limbs Journal of Vascular Medicine and Surgery.2016;4:(2)
  16. Kurklinsky AK, Yataco JC, Yamani MH, Festic E. Case in point. Patent foramen ovale with platypnea-orthodeoxia due to colonic distention. Consultant. 2015 Feb; 55(2):131-2.
  17. Macomb EP, Blair ML, Ashby S, Yamani MH. Strategies To Improve Flow Of Patient Care And Reduce Costs In Outpatient Heart Failure Clinic Utilizing Physician-Nursing Partnership Model Journal of Scientific Research. 2014 Dec; 3(12).
  18. Yamani MH, Nakhleh RE. A Novel Chemical Solution to Demineralize Valvular and Coronary Calcification: Insights from Yogurt and Honey J Cardiovasc Dis Diagn. 2013 Nov 14; 1:130.
  19. Yamani MH. Relation of brain natriuretic peptide level to extent of left ventricular scarring in patients with chronic heart failure secondary to ischemic cardiomyopathy. Am J Cardiol.2009;
  20. Yamani MH. Preoperative Risk Factors for Mortality after Biventricular Assist Device Implantation J Card Failure.2008;
  21. Yamani MH. Hypogammaglobulinemia and infection risk in solid organ transplant recipients Organ Transplantation.2008;
  22. Yamani MH. Myocardial degradation and left bundle branch block predict conversion to low ejection fraction in heart failure with preserved LV systolic function Congestive Heart Failure.2008;
  23. Yamani MH. Thymoglobulin induction and steroid avoidance in cardiac transplantation: results of a prospective randomized, controlled study. Clinical transplantation.2008;
  24. Gonzalez-Stawinski GV, Cook DJ, Chui J, Gupta S, Navia JL, Hoercher K, Taylor DO, Yamani MH, Starling RC, Smedira NG. A comparative analysis between survivors and nonsurvivors with antibody mediated cardiac allograft rejection. J Surg Res. 2007 Oct; 142(2):233-8. Epub 2007 Aug 29.
    View PubMed
  25. Yamani MH, Taylor DO, Haire C, Smedira N, Starling RC. Post-transplant ischemic injury is associated with up-regulated AlloMap gene expression. Clin Transplant. 2007 Jul-Aug; 21(4):523-5.
    View PubMed
  26. Baris N, Sipahi I, Kapadia SR, Nicholls SJ, Erinc K, Gulel O, Crowe TD, Hobbs R, Yamani MH, Taylor DO, Smedira N, Starling RC, Nissen SE, Tuzcu EM. Coronary angiography for follow-up of heart transplant recipients: insights from TIMI frame count and TIMI myocardial perfusion grade. J Heart Lung Transplant. 2007 Jun; 26(6):593-7.
    View PubMed
  27. Gonzalez-Stawinski GV, Cook DJ, Smedira NG, Navia JL, Taylor DO, Yamani MH, Hoercher K, Starling RC, Banbury MK. Attrition from heart transplant waiting list for patients on ventricular assist devices is not affected by desensitization strategies. Transplant Proc. 2007 Jun; 39(5):1571-2.
    View PubMed
  28. Yamani MH, Taylor DO, Rodriguez ER, Cook DJ, Zhou L, Smedira N, Starling RC. Transplant vasculopathy is associated with increased AlloMap gene expression score. J Heart Lung Transplant. 2007 Apr; 26(4):403-6.
    View PubMed
  29. Yamani MH, Starling RC. Heart transplantation: a magnified model of heart-brain interactions. Cleve Clin J Med. 2007 Feb; 74 Suppl 1:S110-3.
    View PubMed
  30. Tayara W, Starling RC, Yamani MH, Wazni O, Jubran F, Smedira N. Improved survival after acute myocardial infarction complicated by cardiogenic shock with circulatory support and transplantation: comparing aggressive intervention with conservative treatment. J Heart Lung Transplant. 2006 May; 25(5):504-9. Epub 2006 Mar 30.
    View PubMed
  31. Haji SA, Avery RK, Yamani MH, Tuzcu EM, Crowe TD, Cook DJ, Mawhorter SD, Hobbs R, Young JB, Smedira N, Starling RC. Donor or recipient hepatitis B seropositivity is associated with allograft vasculopathy. J Heart Lung Transplant. 2006 Mar; 25(3):294-7. Epub 2006 Jan 06.
    View PubMed
  32. Yamani MH. Myocardial upregulation of mRNA Angiotensin II receptor subtype 1 (AGTR1) at one year of heart transplantation is associated with worse long-term clinical outcome including skin cancer Circulation.2006;116:(16)453.
  33. Gonzales-Stawinski G, Cook DJ, Chang AS, Banbury M, Navia J, Hoercher K, Lober C, Atik FA, Taylor DO, Yamani MH, Young JB, Starling RC, Smedira N. Ventricular assist devices and aggressive immunosuppression: looking beyond overall survival. J Heart Lung Transplant. 2006; 25:613-8.
  34. Yamani MH, Chuang HH, Ozduran V, Avery RK, Mawhorter SD, McNeill A, Cook DJ, Buda T, Hobbs RE, Taylor DO, Smedira NG, Starling RC. The impact of hypogammaglobulinemia on infection outcome in patients undergoing ventricular assist device implantation J Heart Lung Transplant. 2006; 25(7):820-4.
  35. Sigurdsson G, Carrascosa P, Yamani MH, Greenberg NL, Perrone S, Lev G, Desai MY, Garcia MJ. Detection of transplant coronary artery disease using multidetector computed tomography with adaptative multisegment reconstruction. JACC. 2006; 48(4):772-8.
  36. Yamani MH, Cook DJ, Rodriguez ER, Thomas DM, Gupta S, Alster J, Taylor DO, Hobbs R, Young JB, Smedira N, Starling RC. Increased expression of angiotensin II type 1 receptor (AGTR1) in heart transplant recipients with recurrent rejection. JHLT. 2006; 25:1283-9.
  37. Starling RC, Pham M, Valantine H, Miller L, Eisen H, Rodriguez ER, Taylor DO, Yamani MH, Kobashigawa J, McCurry K, Marboe C, Mehra MR, Zuckerman A, Deng MC. Working group on molecular testing in cardiac transplantation. Molecular testing in the management of cardiac transplant recipients JHLT. 2006; 25(12):1389-95.
  38. Pervaiz MH, Dickinson MG, Yamani MH. Is Digoxin a drug of the past? Cleveland Clinic J Med. 2006; 73(9):821-38.
  39. Ozduran V, Yamani MH, Chuang HH, Sipahi I, Cook DJ, Sendrey D, Tong L, Hobbs R, Rincon G, Bott-Silverman C, James K, Taylor DO, Young JB, Navia J, Banbury M, Smedira N, Starling RC. Survival beyond 10 years following heart transplantation: The Cleveland Clinic Foundation experience. Transplant Proc. 2005 Dec; 37(10):4509-12.
    View PubMed
  40. Poggio ED, Roddy M, Riley J, Clemente M, Hricik DE, Starling R, Young JB, Gus B, Yamani MH, Heeger PS. Analysis of immune markers in human cardiac allograft recipients and association with coronary artery vasculopathy. J Heart Lung Transplant. 2005 Oct; 24(10):1606-13.
    View PubMed
  41. Erinc K, Yamani MH, Starling RC, Crowe T, Hobbs R, Bott-Silverman C, Rincon G, Young JB, Feng J, Cook DJ, Smedira N, Tuzcu EM. The effect of combined Angiotensin-converting enzyme inhibition and calcium antagonism on allograft coronary vasculopathy validated by intravascular ultrasound. J Heart Lung Transplant. 2005 Aug; 24(8):1033-8.
    View PubMed
  42. O’Neill JO, McRae AT, Troughton RW, Ng K, Taylor DO, Yamani MH, Young JB, Starling RC. Brain natriuretic peptide levels do not correlate with acute cellular rejection in de novo orthotopic heart transplant recipients. J Heart Lung Transplant. 2005; 24(4):416-20.
  43. Yamani MH, Cook DJ, Tuzcu EM, Paul P, Ratliff NB, Yu Y, Hobbs R, Rincon G, Bott-Silverman C, Smedira N, Young JB, Starling RC. Systemic activation of integrin αvβ3 in donors with spontaneous intracerebral hemorrhage is associated with subsequent development of vasculopathy in the heart transplant recipient. J Heart Lung Transplant. 2005; 24(8):1015-18.
  44. Yamani MH, Ratliff NB, Cook DJ, Tuzcu EM, Yu Y, Hobbs R, Rincon G, Bott-Silverman C, Young JB, Smedira N, Starling RC. Peri-transplant ischemic injury is associated with cardiac chimerism and upregulation of stromal cell-derived factor-1 (SDF-1). J Am Coll Card. 2005; 46(6):1029-35.
  45. Yamani MH, Avery R, Mawhorter SD, McNeill A, Cook DJ, Ratliff NB, Pelegrin D, Colosimo PJ, Kiefer K, Ludrosky K, Hobbs R, Taylor D, Buda T, Yeager M, Young JB, Smedira N, Starling RC. The impact of CytoGam on cardiac transplant recipients with moderate hypogammaglobulinemia: a randomized single center study. J Heart Lung Transplant. 2005; 24(11):1766-9.
  46. Yamani MH, Erinc SK, McNeill A, Ratliff NB, Sendrey D, Zhou L, Cook DJ, Hobbs R, Rincon G, Bott-Silverman C, Young JB, Banbury M, Navia J, Smedira N, Starling RC. The impact of donor gender on cardiac peri-transplant ischemic injury. J Heart Lung Transplant. 2005; 24(11):1741-44.
  47. Erinc K, Yamani MH, Starling RC, Young JB, Crowe T, Ratliff NB, Cook DJ, Hobbs R, Bott-Silverman C, Rincon G, Smedira N, Tuzcu EM. The influence of donor gender on allograft vasculopathy: evidence from intravascular ultrasound. Transplant Proc. 2004 Dec; 36(10):3129-31.
    View PubMed
  48. Goetze S, Sigurdsson G, Greenberg NL, Yamani H, Garcia MJ. Images in cardiovascular medicine. Transplant vasculopathy: evaluation with multi-detector computed tomography. Circulation. 2004 Aug 31; 110(9):e80-1.
    View PubMed
  49. Nash PJ, Avery RK, Tang WH, Starling RC, Taege AJ, Yamani MH. Encephalitis owing to human herpesvirus-6 after cardiac transplant. Am J Transplant. 2004 Jul; 4(7):1200-3.
    View PubMed
  50. Yamani MH, Cook DJ, Tuzcu EM, Abdo A, Paul P, Ratliff NB, Yu Y, Yousufuddin M, Feng J, Hobbs R, Rincon G, Bott-Silverman C, McCarthy PM, Young JB, Starling RC. Systemic up-regulation of angiotensin II type 1 receptor in cardiac donors with spontaneous intracerebral hemorrhage. Am J Transplant. 2004 Jul; 4(7):1097-102.
    View PubMed
  51. Haji SA, Starling RC, Avery RK, Mawhorter S, Tuzcu EM, Schoenhagen P, Cook DJ, Ratliff NB, McCarthy PM, Young JB, Yamani MH. Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation. J Heart Lung Transplant. 2004 Mar; 23(3):277-83.
    View PubMed
  52. Yousufuddin M, Haji S, Starling RC, Tuzcu EM, Ratliff NB, Cook DJ, Abdo A, Saad Y, Karnik SS, Wang D, McCarthy PM, Young JB, Yamani MH. Cardiac angiotensin II receptors as predictors of transplant coronary artery disease following heart transplantation. Eur Heart J. 2004 Mar; 25(5):377-85.
    View PubMed
  53. Yamani MH, Lauer MS, Starling RC, Pothier CE, Tuzcy EM, Ratliff NB, Cook DJ, Abdo A, McNeill A, Crowe T, Hobbs, R, Rincon G, Bott-Silverman CB, McCarthy PM, Young JB. Impact of donor spontaneous intracranial hemorrhage on outcome following heart transplantation. Am J Transplant. 2004; 4:257-61.
  54. Yamani MH, Yousufuddin M, Starling RC, Tuzcu EM, Ratliff NB, Cook DJ, Abdo A, Crowe T, Hobbs R, Rincon G, Bott-Silverman C, McCarthy PM, Young JB. Does acute cellular rejection correlate with cardiac allograft vasculopathy? J Heart Lung Transplant. 2004; 2(3):272-76.
  55. Yousufuddin M, Cook DJ, Starling RC, Abdo A, Paul P, Tuzcu EM, Ratliff NB, McCarthy P, Young JB, Yamani MH. Angiotensin II type receptors from peri-operation through first year post-transplantation and the risk of transplant coronary artery disease. J Am Coll Card. 2004; 43(9):1565-73.
  56. Yousufuddin M, Yamani MH. The renin-angiotensin hypothesis for the pathogenesis of cardiac allograft vasculopathy. Int J Card. 2004; 95(2-3):123-7.
  57. Yamani MH, Erinc K, Starling RC, Young JB, Ratliff NB, Cook DJ, Crowe T, Hobbs R, Rincon G, Bott-Silverman C, Bennett R, Smedira N, Tuzcu EM. Donor intracranial bleeding is associated with advanced transplant coronary vasculopathy: Evidence from intravascular ultrasound. Transplant Proc. 2004; 36(9):2564-66.
  58. Yamani MH, Starling RC. Surrogate markers of transplant vasculopathy. Curr Opin Organ Transplant. 2004; 9:443-7.
  59. Masri SC, Yamani MH, Russell MA, Ratliff NB, Yang J, Almasan A, Apperson-Hansen C, Li J, Starling RC, McCarthy P, Young JB, Bond M. Sustained apoptosis in human cardiac allografts despite histologic resolution of rejection. Transplantation. 2003 Sep 15; 76(5):859-64.
    View PubMed
  60. Fahmy NM, Yamani MH, Starling RC, Ratliff NB, Young JB, McCarthy PM, Feng J, Novick AC, Fairchild RL. Chemokine and receptor-gene expression during early and late acute rejection episodes in human cardiac allografts. Transplantation. 2003 Jun 27; 75(12):2044-7.
    View PubMed
  61. Fahmy NM, Yamani MH, Starling RC, Ratliff NB, Young JB, McCarthy PM, Feng J, Novick AC, Fairchild RL. Chemokine and chemokine receptor gene expression indicates acute rejection of human cardiac transplants. Transplantation. 2003 Jan 15; 75(1):72-8.
    View PubMed
  62. Khot UN, Mishra M, Yamani MH, Smedira NG, Paganini E, Yeager M, Buda T, McCarthy PM, Young JB, Starling RC. Severe renal dysfunction complicating cardiogenic shock is not a contraindication to mechanical support as a bridge to cardiac transplantation. J Am Coll Card. 2003; 41(3):381-5.
  63. Yamani MH, Starling RC, Cook DJ, Tuzcu EM, Abdo A, Paul P, Powell K, Ratliff NB, Yu Y, McCarthy PM, Young JB. Donor spontaneous intracerebral hemorrhage is associated with systemic activation of MMP-2 and MMP-9 and subsequent development of coronary vasculopathy in the heart transplant recipient. Circulation. 2003; 108:1724-28.
  64. Ferri C, Properzi G, Tomassoni G, Santucci A, Desideri G, Giuliani AE, Starling RC, Ratliff NB, Cook DJ, McCarthy P, Young JB, Yamani MH. Patterns of myocardial endothelin-1 expression and outcome after cardiac transplantation. Circulation. 2002 Apr 16; 105(15):1768-71.
    View PubMed
  65. Yamani MH, Yang J, Masri S, Ratliff NB, Bond M, Starling RC, McCarthy P, Plow E, Young JB. Acute cellular rejection is associated with increased expression of vitronectin receptor (Integrin alphavbeta3). Am J Transplantation. 2002; 2:129-33.
  66. Yamani MH, Masri S, Ratliff NB, Bond M, Starling RC, Tuzcu M, McCarthy P, Young JB. The role of vitronectin receptor (alphavbeta3) and tissue factor in the pathogenesis of transplant vasculopathy. J Am Coll Cardiol. 2002; 39(5):804-10.
  67. Yamani MH, Haji SA, Starling RC, Tuzcu EM, Ratliff NB, Cook DJ, Abdo A, Crowe T, McCarthy PM, Young JB. Myocardial ischemic-fibrotic injury following human heart transplantation is associated with increased progression of vasculopathy, decreased cellular rejection, and poor long-term outcome. J Am Coll Cardiol. 2002; 39:970-77.
  68. Yamani MH, Tuzcu EM, Starling RC, Young JB, Hobbs R, Cook DJ, Haji SA, Abdo S, Crowe T, Secic M, McCarthy PM, Ratliff NB. A novel method based on computerized scoring of histopathology for the prediction of coronary vasculopathy, validated by Intravascular Ultrasound. J Heart Lung Transplant. 2002; 21(8):850-59.
  69. Yamani MH, Tuzcu EM, Starling RC, Ratliff NB, Yu Y, Vince GD, Powell K, Cook D, McCarthy P, Young JB. Myocardial ischemic injury following heart transplantation is associated with upregulation of vitronectin receptor (alphavbeta3), activation of the matrix metalloproteinase induction system, and subsequent development of coronary vasculopathy. Circulation. 2002; 105:1955-61.
  70. Yamani MH, Starling RC, Young JB, Cook D, Yu Y, Geoffrey V, McCarthy P, Ratliff NB. Acute vascular rejection is associated with up-regulation of vitroncetin receptor (alpha v beta 3), increased expression of tissue factor, and activation of the extracellular matrix metalloproteinase induction system. J Heart Lung Transplant. 2002; 21(9):983-9.
  71. Yamani MH, Kinter MT, Starling RC, Willard BB, Ratliff NB, Yu Y, Cook D, McCarthy M, Young JB. Increased beta-myosin heavy chain in acute cellular rejection following human heart transplantation. Am J Transplantation. 2002; 2:386-8.
  72. Yamani MH. Diastolic heart failure. Men's Health Advisor; 2002; 4(8):6-7.
  73. Yamani MH, Young J. Chemokines in cardiovascular diseases: from atherosclerosis and heart failure to allograft arteriopathy. Graft. 2002; 5(4):205-11.
  74. Yamani MH, Haji S, Starling RC, Kelly L, Albert N, Knack DL, Young JB. Comparison between Dobutamine and Milrinone based therapy for acute exacerbation of congestive heart failure: hemodynamic efficacy, clinical outcome, and economic cost. Am Heart J. 2001 Dec; 142(6):998-1002.
  75. Shen B, Younossi ZM, Dolmatch B, Newman JS, Henderson JM, Ong JP, Gramlich T, Yamani M. Patent ductus venosus in an adult presenting as pulmonary hypertension, right-sided heart failure, and portosystemic encephalopathy. Am J Med. 2001 Jun 1; 110(8):657-60.
    View PubMed
  76. Jimenez J, Kapadia SR, Yamani MH, Platt L, Hobbs RE, Rincon G, Botts-Silverman C, Starling RC, Young JB, Nissen SE, Tuzcu M, Ratliff NB. Cellular rejection and rate of progression of transplant vasculopathy: a 3-year serial intravascular ultrasound study. J Heart Lung Transplant. 2001 Apr; 20(4):393-8.
    View PubMed
  77. Yamani MH, Avery R, Mawhorter S, Young JB, Hobbs R, McCarthy PM, Smedira N, Hoercher K, Ratliff NB, Goormastic M, Pelegrin D, Starling RC. Hypogammaglobulinemia following cardiac transplantation: a link between infection and acute cellular rejection. J Heart Lung Transplant. 2001; 20(4):425-30.
  78. Yamani MH, Avery R, Mawhorter S, Young JB, McNeill A, Cook DJ, Ratliff NB, McCarthy P, Starling RC. Hypogammaglobulinemia after heart transplantation: impact of pre-emptive use of immunoglobulin replacement (CytoGam) on infection and rejection outcomes. Transplant Infectious Disease. 2001; 3:40-3.
  79. Yamani MH. When should digoxin be used in patients with diastolic dysfunction. The Cleveland Clinic J of Med. 2001; 68(6):481-5.
  80. Yamani MH, Starling RC, Pelegrin D, Platt L, Majercik M, Hobbs RE, Mc Carthy P, Young JB. Efficacy of tacrolimus in patients with steroid-resistant cardiac allograft cellular rejection. J Heart and Lung Transplant. 2000; 19:337-42.
  81. Yamani MH, Starling RC, Van Lente F, Goormastic M, Smedira N, McCarthy P, Young JB. The impact of routine mycophenolate mofetil drug monitoring on the treatment of cardiac allograft rejection. Transplantation. 2000; 69(11):2326-30.
  82. Yamani MH, van de Poll S, Ratliff NB, Kuban BE, Starling RC, McCarthy P, Young JB. Fluorescence spectroscopy of endomyocardial tissue post human heart transplantation: Does it correlate with histopathology. J Heart Lung Transplant. 2000; 19:1077-80.
  83. Yamani MH, Starling RC. Long-term medical complications of heart Transplantation: Information for the Primary Care Physician. The Cleveland Clinic J of Med. 2000; 67(9):673-81.
  84. Cook DJ, Bishay ES, Yamani MH. The use and misuse of Immunologic Monitoring after transplantation. Curr Opinion Cardiol J. 2000; 15:104-7.
  85. Yamani MH, Wells L, Massie BM, Ammon S, Der E, Prouty K. Relation of the nine-minute self-powered treadmill test to maximal exercise capacity and skeletal muscle function in patients with congestive heart failure. Am J Cardiol. 1995 Oct 15; 76(11):788-92.
    View PubMed
  86. Yamani MH, Sahgal P, Wells L, Massie BM. Exercise intolerance in chronic heart failure is not associated with impaired recovery of muscle function or submaximal exercise performance J Am Coll Card. 1995; 25(6):1232-38.
  87. Yamani MH, Massie BM. Hypertension, myocardial ischemia, sudden death Curr Opin Cardiol. 1994; 9(5):542-50.
  88. Yamani M, Massie BM. Congestive heart failure: insights from epidemiology, implications for treatment. Mayo Clin Proc. 1993; 68(12):1214-18.
  89. Malouf J, Yamani M, Dagher I, Kaid S, Alam S. Two dimensional echocardiographic demonstration of an unusual complication of aortic infective endocarditis. Acta Cardiol. 1984; 39(5):379-86.
    View PubMed